Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal (GlobeNewswire)

Biomerica’s inFoods® IBS blood test is transforming Irritable Bowel Syndrome (IBS) management by identifying personalized dietary triggers, significantly reducing abdominal pain and bloating. A placebo-controlled trial of 238 IBS patients found that 59.6% of patients eliminating their specific trigger foods experienced pain relief, compared to 42.2% in the control group. Results were most pronounced in IBS-C (67.1%) and IBS-M (66%) patients.